Table 8.
Baseline clinical variables in the groups based on reduction of protein excretion in urine < 1.0 g/24 h.
| Parameter | Proteinuria Reduction < 1.0 g/day | p-Value | |
|---|---|---|---|
| Yes (N = 23) | No (N = 15) | ||
| Age (years) | 45 ± 16 | 41 ± 15 | 0.42 |
| SBP (mmHg) | 135 ± 15 | 129 ± 14 | 0.24 |
| DBP (mmHg) | 80 ±9 | 79 ±9 | 0.55 |
| MAP (mmHg) | 97 ± 10 | 94 ± 9 | 0.36 |
| NLR | 2.3 ± 1.4 | 2.6 ± 2.2 | 0.56 |
| PLR | 144 ± 59 | 141 ± 55 | 0.87 |
| Total cholesterol (mg/dL) | 327± 130 | 274 ± 114 | 0.2 |
| Triglycerides (mg/dL) | 198 ± 118 | 191± 98 | 0.84 |
| Uric acid (mg/dL) | 6.9 ± 2 | 6.8 ± 1.7 | 0.81 |
| Fasting glucose (mg/dL) | 95 ± 14 | 90 ± 8 | 0.81 |
| Serum albumin (g/dL) | 2.8 ± 0.9 | 3.0 ± 0.9 | 0.49 |
| Total protein (g/dL) | 5.2 ± 1 | 5.4 ± 1.5 | 0.67 |
| Serum creatinine (mg/dL) | 1.6 ± 2.5 | 1.3 ± 0.4 | 0.7 |
| eGFR (mL/min/1.73 m2) | 71 ± 28 | 62 ± 21 | 0.32 |
| UPCR (g/g) | 3.6 ± 2.5 | 3.2 ± 2 | 0.32 |
| Erythrocyturia—moderate | 10 (43%) | 8 (53%) | 0.55 |
| Erythrocyturia—severe | 7 (30%) | 1 (7%) | 0.18 |
| Hypertension | 13 (57%) | 8 (54%) | 0.85 |
| ACEI treatment | 14 (61%) | 11 (73%) | 0.66 |
| Immunosuppression use at the time of biopsy | 8 (35%) | 4 (27%) | 0.6 |
| Immunosuppression use after biopsy | 23 (100%) | 15 (100%) | 1.0 |